Objectives: Sepsis therapies have proven to be elusive because of the difficulty of translating biologically sound and effective interventions in animal models to humans. A part of this problem originates from the fact that septic patients present at various times after the onset of sepsis, whereas the exact time of infection is controlled in animal models. We sought to determine whether data mining longitudinal physiologic data in a nonhuman primate model of Escherichia coli-induced sepsis could help inform the time of onset of infection. Design: A nearest-neighbor approach was used to back cast the time of onset of infection in animal models of sepsis. Animal data were censored to simulate prospective monitoring at any moment along the septic infection. This was compared against an uncensored database to find the most similar animal in order to estimate the infection onset time. Leave-one-out cross-validation was used for validation. Biomarker selection was performed based on the criteria of estimation accuracy and/or ease of measurement. Setting: Computational experimental on existing experimental data. Subjects: Retrospective data from 33 septic baboons (Papio ursinus) subjected to Escherichia coli infusion. Validation was performed using 14 pigs that were subjected to surgically induced fecal peritonitis and 22 pigs that were subjected to lipopolysaccharide infusion. Measurements and Main Results: Longitudinal physiologic and serum markers, time of death. The presence of uniquely changing biomarkers during septic infection enabled the estimation of infection onset time in the datasets. Various combinations of temporal biomarkers, such as WBC, oxygen content, mean arterial pressure, and heart rate, yielded estimation accuracies of up to 97.8%. The use of temporal vital signs and a single measurement of serum biomarkers yielded highly accurate estimates without the need for invasive measurements. Validation in the pig data revealed similar results despite the heterogeneity of multiple experimental cohorts. This suggests that the method may be effective if sufficiently similar subjects are present in the database. Conclusions: One nearest-neighbor analysis showed promise in accurately identifying the onset of infection given a database of known infection times and of sufficient breadth. We suggest that this approach is ready for evaluation within the clinical setting using human data. (Crit Care Med 2016; 44:e432-e442) 
S epsis is a severe acute physiologic response that results from the systemic effects of inflammatory mediators in response to infection. Each year, sepsis afflicts millions worldwide with extensive morbidity and mortality (1) . Treatment of sepsis has proven to be a challenge because of the fastchanging dynamics and multiple trajectories and outcomes of the syndrome (2, 3) . Progress in sepsis therapeutics has generally been slow. Since 1982, clinical trials for pharmacologic interventions in sepsis showed either no effect or a negative effect on mortality (4) . There is currently no Food and Drug Administration-approved drug to treat septic shock. Frustratingly, therapies that have shown promise in animal models have often failed in human trials because of a lack of efficacy or safety concerns (5, 6) . Part of this translational disconnect originates from the fact that septic patients are admitted into the hospital at various times after the onset of sepsis symptoms (7, 8) . Data collection and treatment initiation are performed relative to the time of enrollment, not to the time of disease onset. Because of the dynamic nature of the physiologic response to infection, both the nature and the timings of potential interventions are likely to be determinant factors in influencing outcome (2, 9) . For example, an abrogation of the early tumor necrosis factor response increased mortality in some animal models, whereas most preclinical treatment models showed benefit (10, 11) . This may explain, at least in part, why many sepsis therapies that showed promise from animal models, where timing is known, failed in human studies.
Several mathematical and statistical models have been posed to elucidate the fast-acting dynamics of sepsis and to offer predictions regarding the potential effects of interventions and their timing (2, 3, 12, 13) . However, training and fitting parameters of these models for individual patients is challenging, in part, due to the aforementioned timing issues with human data collection. For the purposes of such models, a population mean is typically computed from data pooled at time points relative to the time of enrollment. Naive pooling becomes a problem because these data points are located at various points along temporal trajectories of individual patients. Methodological obstacles in developing robust models, such as interindividual timing and variability and response, combined with a lack of familiarity of the research community with such computational tools have delayed the introduction of such advanced tools as core to the design of clinical trials of sepsis.
Identifying the time of onset of infection offers two advantages in human sepsis research. First, it potentially enables the revisiting of previously failed trials with the purpose of analyzing, a posteriori, possible relationships between the elapsed time from onset and effectiveness. Second, identifying onset time enables patient biomarker data to be shifted relative to the time of infection, therefore allowing more effective translation between animal results and human expectations. Furthermore, mathematical models can be properly trained and provide more accurate predictions if mechanistically based, biomarker-driven interventions are contemplated. We present an approach that, at least in three animal models, accurately estimates the time of onset of an inflammatory challenge from commonly obtained measurements.
METHODS

Datasets
A baboon sepsis dataset was retrospectively analyzed for this work (14) . The original experimental design was to investigate the therapeutic effects of a nitric oxide synthase (NOS) inhibitor on septic shock. Thirty-three baboons of the species Papio ursinus were sedated, and 2 × 10 9 colony forming units per kilogram of Escherichia coli (E. coli) were infused IV into each subject over 2 hours. Fluid resuscitation and antibiotic therapy were provided to all subjects throughout the experiment. The proposed NOS inhibitor treatment began after hour 12 on 16 subjects. Animals were treated in accordance with National Institutes of Health guidelines. The experimental protocol was reviewed and approved by the Institutional Animal Care and Use Committee of Biocon Research Laboratories, Pretoria, South Africa. Seventy-three biomarkers were obtained as time series for each baboon, including vital signs, arterial blood gases and lactate, hemodynamic variables, complete blood counts and differential, and biochemistry. Baseline measurements were taken 30 minutes prior to E. coli infusion. Additional measurements were collected at specified times throughout the experiment. Subjects that survived the experiment had final measurements taken prior to killing. Biomarkers that were intermittently measured throughout the experiment were eliminated from the analysis. This reduced the number of biomarkers to 29, where measurements were available for all baboons at hours −0.5, 0, 0.5, 1, 2, 3, 4, 5, 6, 11, and 12, where hour 0 marked the beginning of the E. coli infusion. This time point was considered the true time of onset of infection. Time points past 12 hours post infection were not used in this analysis. Baboons in the sham and treatment groups were combined for analysis. The biomarkers evaluated herein are listed in Table 1 .
For validation of the method, two porcine datasets were used. The first dataset included 14 pigs that were subjected to surgically induced peritonitis; of which, seven subjects received a superoxide dismutase treatment. Measurements were collected at 2, 4, 6, 8, 10, and 12 hours after abdominal closure. Both groups were combined during analysis because trajectories between groups were not significantly different. The second dataset included 22 pigs subjected to 1-hour lipopolysaccharide (LPS) infusions: 12 subjects received 1 μg/kg/hr and 10 received 10 μg/kg/hr. Half of the animals received biliverdin. Measurements were collected at 0, 1, 2, 3, 4, 5, and 7 hours after the start of LPS infusion. Despite significant differences in trajectories between LPS doses, all groups were combined during analysis to test the method's performance on a nonhomogenous database. In both porcine studies, baboon-comparable biomarkers were used. Figure 1 provides an illustration of the process to estimate the time of onset of infection for a given subject. The temporal trajectories of biomarkers for this subject were left censored at all possible time points to simulate prospective monitoring at any given moment along the subject's sepsis trajectory. Trajectories were right censored to 1, 2, 3, or 4 consecutive points to simulate a time period of monitoring. The one-nearestneighbor method compared the subject's subtrajectory against a database of equal length from the remaining 32 subjects, identified the most similar subtrajectory, and assigned the time of onset as the known time of onset for the most similar subtrajectory.
One-Nearest-Neighbor Analysis
Suppose a 3-hour WBC data segment was available for a study subject. A Euclidean distance was calculated between this segment and all possible three consecutive WBC points in the database. Figure 2 conceptualizes this methodology. This Widely accepted noninvasive methods exist to obtain or closely estimate this value. Acronyms used for physiological measurements obtained longitudinally in the animal experiments, the means through which these measurements were obtained, and whether these means are considered invasive, minimally invasive, or noninvasive. The third column indicates how the biomarker was measured within the baboon data. The right most column indicates the feasibility of measuring the biomarker in patients within a clinical setting.
Critical Care Medicine www.ccmjournal.org e435 process was repeated for each additional biomarker, and their distances were summed. The 3-hour length subtrajectory in the database with the shortest distance to the study subject's was identified as the nearest neighbor. The first time point of this subtrajectory was used to estimate the study subject's elapsed time since infection. Using more than one nearest neighbor was tested, but it did not improve the accuracy of results (data not shown). A glossary of terms and detailed procedures used are provided in the supplemental data (Supplemental Digital Content 1, http://links.lww.com/CCM/B658).
To account for scaling differences across biomarkers and for interbaboon variability, data were normalized on a per-baboon basis. Each subject's biomarker trajectories were normalized to its respective baseline (value at t = −0.5 hr prior to infusion). However, the baseline values for the study subject were unknown because of left censoring. A linear regression model for estimating baseline was created for each biomarker using all time points in the database (biomarker baseline = β 0 + β 1 × biomarker t ). This was used to estimate the unknown baseline values and normalize each biomarker for the study subject. The intercept, β 0 , represents a population average baseline, and the slope variable, β 1 , represents a subject-specific shift to this baseline.
To test estimation accuracy, we use leave-one-out validation. For each of the 33 subjects, every possible left censoring within the interval (0.5 hr, 12 hr) was tested to emulate a maximum of nine possible "arrival" times. Estimations were generated for each of these cases, and accuracy was determined by dividing the number of correct estimations by the total number of estimations generated. An estimated infection time within a tolerance of ± 1 time point from the actual infection time was deemed correct.
In Silico Experiments
A combinatorial search was performed in order to find the set of biomarkers that yielded the highest accuracy in estimating time of infection while minimizing the number of invasive clinical measurements required. The majority of the 29 biomarkers within the dataset were the result of invasive measurements, and some of these are difficult to collect from human patients. To improve the clinical feasibility of the method, the search was performed involving single-point measurements of minimally invasive biomarkers, that is, blood samples and vital signs.
The first accuracy experiment tested the individual estimation capacity for time of onset of each of the 29 biomarkers across various levels of right censoring. The best biomarkers were identified by calculating the mean accuracy across the four right censoring durations and selecting the top 10. In addition, the null hypothesis was tested by making estimations based on randomly generated trajectories sampled from a zero mean log normal distribution. The second accuracy experiment exhaustively searched all possible combinations of the previously identified top 10 biomarkers. A combinatorial 10 C n search, where n ϵ {2, 3,..., 10} was performed to identify the best n combinations of biomarkers that identify infection time. This search was performed for each of the right censoring options.
The first feasibility experiment tested the ability of a mixture of time series biomarkers and single-point measure biomarkers to estimate infection time. Vitals heart rate (HR), mean arterial blood pressure (MAP), temperature, arterial oxygen saturation (SATAo 2 ), and respiratory rate (RR) are noninvasive to measure and were made available in time series. Minimally invasive biomarkers WBC, Pao 2 , and platelet count (PLT) were chosen because of their diagnostic abilities as listed in the Surviving Sepsis Guidelines (1). In addition, the top three minimally invasive biomarkers from the first accuracy experiment were included as well. All combinations of these vitals and minimally invasive biomarkers were tested for their infection time estimation accuracy. This experiment was repeated for right censoring at 2, 3, and 4 hours. The second feasibility experiment further explored this combination of time series biomarkers and single-point biomarkers by comparing two diagnostic panels that can be realistically performed at the time of patient enrollment. Two minimally invasive diagnostic panels were chosen: arterial blood gas test (yielding arterial base excess, Pao 2 , and arterial bicarbonate [HCO3A]) and blood analysis (yielding WBC, PLT, and hemoglobin). Similar to before, vitals were available in time series, and this panel of biomarkers was available at the time of simulated enrollment for a given emulated patient. All combinations of the aforementioned vitals (except for RR) were tested with data from either or both diagnostic panels. RR was excluded because it was not among the top performers in the previous experiment. This experiment was repeated for right censoring at 2, 3, and 4 hours.
For validation, the first accuracy experiment (single-biomarker search) and the first feasibility experiment (vitals + one search) were repeated on each of the pig datasets. The biomarkers used in those experiments were selected to be comparable with those of the baboons. Table 2 shows the infection time estimation accuracy of individual biomarkers. The first right censor duration tested only a single-time measurement and yielded low accuracies throughout the table. Accuracy increased as more of the study subject's temporal points were included in the search. Biomarkers were sorted by decreasing mean accuracy across the four right censor durations. WBC was the top biomarker in all columns and yielded a maximum estimation accuracy of 93.1% when using four sequential hourly points. Jackknife resampling of the data revealed that the sd of accuracies across biomarkers and right censor durations had a mean of 0.7%. No entry within Table 2 fell below their respective right censor level null accuracy. The mean null hypothesis accuracy increased with higher right censor levels because of the shrinking of estimation possibilities. All possible combinations of the top 10 biomarkers from Table 2 were tested to maximize the accuracy at each level of right censorship. The top result for each right censor level is shown in Table 3 . Remarkably, single-time point measurements of six biomarkers yielded roughly 70% estimation accuracy. WBC was selected in all cases. There was a strong preference given to arterial blood gas measurements, hemoglobin, and cardiovascular measurements.
RESUlTS
Accuracy Experiments
Feasibility Experiments
The goal of the feasibility experiments was to identify a parsimonious set of biomarkers, in both time series and single-point measurements, which were minimally invasive to measure in humans and yielded a good accuracy in their ability to estimate the time of infection onset. HCO3A, hemoglobin, and cardiac output (CO) were the top performing minimally invasive biomarkers in Table 2 and were included in the experiment. Table 4 shows the best results from each measurement collection (one minimally invasive biomarker plus a combination of vitals in time series) organized by right censor duration. For comparison, accuracies were calculated for each entry with vitals alone and with all biomarkers in time series. The inclusion of a point measurement had the greatest impact on accuracy for the lower right censor durations. A single value of WBC combined with 2 hours of HR data improved accuracy from 58.2% to 71.4%. HCO3A and WBC were consistently selected throughout the table. Point measures of biomarkers helped many entries achieve over 90% estimation accuracy.
Time series of invasive measurements did not improve accuracy, thus not warranting the extra probing of subjects. For example, two measurements of HR and WBC yielded an estimation accuracy of 81.1%. The same accuracy was achieved by using two measurements of MAP and HR along with a single measurement of HCO3A. Furthermore, the use of MAP, SATAo 2 , and HR + 1× HCO3A outperformed the majority of entries in each right censor category.
The second feasibility experiment tested the accuracy of using multiple single-point biomarkers with time series vitals. The top three results from the combinatorial search are shown in Table 5 with results sorted based on accuracies from the "both panels'" column. The information gained by administering both diagnostic panels aided in almost all entries of the 2-and 3-time point right censor levels, achieving maximum accuracies of 84.2% and 90.2%, respectively. Regardless, despite the added data from the diagnostic panels, many entries from Table 4 using a point biomarker yielded equal or higher accuracies. Table 2 shows single-biomarker accuracies for both pig experiments. Accuracies were, in general, equivalent or higher than those of the baboons. Time of onset estimation differed slightly among the models. For example, hemoglobin, temperature, and hematocrit performed better in both of the pig datasets. Alternatively, PLT performed similarly between the baboon and the pig LPS data but was more informative in the pig peritonitis data. This may be the result of the differences in sepsis induction protocols across the three models and suggestive toward the existence of sepsis endotypes characterized by distinctive biomarker trajectories.
Method Validation on Porcine Datasets
The vitals + one biomarker search on the porcine data revealed MAP, temperature, and SATAo 2 to provide highly accurate estimates (LPS: 70-90+%; peritonitis: 80-90+%) when used in conjunction with a single WBC or arterial pH measurement. Detailed porcine results from this search are available in Supplemental Tables 1 and 2 (Supplemental Digital Content 1, http://links.lww.com/CCM/B658).
DISCUSSION
A one-nearest-neighbor approach was selected to tackle the problem of identifying infection time from left and right censored data. We found that serial measurements of noninvasive vital signs, combined with a single minimally invasive, yet routinely done, blood work, yielded good accuracy to identify time of onset of infection in an experimental baboon model of sepsis. The method was further confirmed in two additional animal models. The one-nearest-neighbor method was developed based on the hypothesis that cohorts of septic subjects exist with similar characteristic biologic responses. The baboon HR = heart rate, HCO3A = arterial bicarbonate, MAP = mean arterial blood pressure, SATAo 2 = arterial oxygen saturation, TEMP = temperature, HB = hemoglobin.
Results from the first feasibility experiment where vital signs in time series were combined with single-point measurements (at the time of simulated enrollment) of minimally invasive biomarkers to estimate infection time. Vitals temperature, mean arterial blood pressure, arterial oxygen saturation, heart rate, respiratory rate, or in any combination thereof, was tested in conjunction with a single blood biomarker for their prediction accuracy. The top three biomarker sets for each combination and right censor duration are shown, with their accuracies listed in the "with point" column. "No point" shows the estimation accuracy for the vitals without the point biomarker. "Time series point" shows the estimation accuracy when all biomarkers (vitals and point) were available in time series.
study chosen for analysis represented a homogenous cohort that all exhibited leukopenia following the E. coli infusion. Pig validation sets did not share this feature. Given a censored and normalized trajectory for a study baboon, one-nearest-neighbor identified the most similar trajectory within the database.
The temporal information of this trajectory provided the timeof-infection estimate for the study baboon. To the best of our knowledge, there are currently no proposed methods to identify time of onset of an inflammatory challenge for sepsis or nonsepsis data. A related article was found to use a variable k-nearest-neighbor approach for the purposes of early diagnosis in neonatal sepsis (15) . Another recent article used the nearest-neighbor approach to identify novel genes associated with sepsis severity (16) . Nearest-neighbor approach is a popular nonparametric approach in data mining and was selected here to find similarities among biomarker trajectories. The exhaustive biomarker search revealed that certain biomarkers provide highly accurate estimations of time of onset of infection. WBC, HR, hemoglobin, MAP, and HCO3A were the top performers in Table 2 and had many appearances in Table 3 . In contrast to CO or systemic vascular resistance (SVR), both of which require the insertion of an arterial catheter, WBC, HR, hemoglobin, MAP, and HCO3A are relatively easy to measure. The modest accuracy increase from the inclusion of CO or SVR is of doubtful clinical significance and did not seem to justify the invasive measurement. This suggested that more invasive-to-measure biomarkers might be unnecessary and that this time of infection onset can be estimated with easily measured, patient-friendly biomarkers. It is also interesting to note the consistent appearance of many biomarkers across animal models.
Most clinicians do not perform consecutive hourly blood sample tests, and only noninvasive biomarkers are likely to be acquired in time series. Many biomarkers in the baboon data cannot be obtained hourly (or ever) in human patients because of practical reasons (no available commercial assay, slow turnovers) or to unjustifiable expenses. Patients with suspected sepsis upon enrollment sometimes have a panel of diagnostic tests administered, including arterial blood gas tests and a WBC measurement. These measurements are typically only taken once at the time of enrollment. In contrast, vital signs such as HR, MAP, temperature, and SATAo 2 are continuously monitored and universally measured in time series. The feasibility experiments addressed these issues by using clinically obtainable data from humans and yielded interesting results. Specifically, they showed that 1) the addition of a minimally invasive point measurement generally improved time-ofinfection accuracy over the use of time series vitals alone, 2) taking minimally invasive measurements in time series may be unnecessary for estimating time-of-infection, and 3) there existed a data saturation limit where one-nearest-neighbor did not benefit from additional data.
The main limitation associated with this method was the small sample size of all three datasets. This method worked well for the heterogeneous pig datasets at least, in part, because of the uniformity of the insult within datasets, thus improving the chances of a relevant "closest looking" animal in the cohort. If the database does not contain sufficiently similar subjects to an incoming subject for which an estimation is to be made, the method might not be able to generate a meaningful estimate.
Three main challenges currently prevent this method from being directly translated to human patients. First, developing a human model requires access to a temporally rich collection of physiologic markers at baseline and following time of infection. The second challenge is human variability, demanding that the dataset be of sufficient size to be representative on most endotypes. Third, human sepsis often happens in conjunction with other inflammatory stressors, such as surgery or trauma. To address these challenges, a human dataset of sufficient breadth could potentially be assembled in a cohort of patients developing sepsis in association with an invasive procedure, therefore bounding time of onset to within a few hours. The impact of the procedure itself on biomarker time series would constitute useful additional information.
Although human patients exhibit high variability, we argue that there exists a finite number of sepsis endotypes and that these endotypes can be grouped into cohorts with similar clinical biomarker trajectories. Future work will employ data-mining techniques to classify these endotypes and to identify the associated biomarkers. By informing a nearest-neighbor search on a sufficiently varied database with endotype-indicative biomarkers, the method should have enough discrimination to generate meaningful estimates of sepsis onset times.
CONClUSIONS
We propose a novel application of the nearest-neighbor approach to estimate the onset time of infection within artificially censored baboon and porcine sepsis data. High accuracies were achieved with varying sets of biomarkers, but some biomarkers are difficult to measure clinically in humans. A compromise was made between minimizing the invasiveness of measurement and maximizing the estimation accuracy. A feasible set of clinically measurable biomarkers was identified; combinations of vital signs in time series and minimally invasive point measurements yielded similar but slightly lower accuracies.
There are no other approaches to estimating time of -infection in sepsis, and the method developed here may have profound implications if successfully extended for use with human data. Septic patients would be able to be grouped into early, middle, and late infection times and treated differently, which may play a clinically meaningful role in patient outcomes. Clinical trials may be revisited or new therapeutic targets may emerge because treatment timings can be more effectively controlled with respect to the temporal span of infection. Finally, computational models of sepsis and immunomodulatory interventions used in the design of such trials may immediately benefit from the knowledge of infection times.
